DrugAnalyst Consensus Database
DRUGANALYST LTD
172 TOTTENHAM COURT RD
LONDON W1T 7NS
+44 20 3696 7500
Log In
This site is best viewed with JavaScript enabled
Company
Sector
Drugs
Valuation
Portfolio
Get Access
European Pharma
AstraZeneca
Bayer
BTG
Fresenius
FMC
Galapagos
Genmab
Glaxo
Grifols
Indivior
Ipsen
Lundbeck
Merck KGaA
Novartis
Novo Nordisk
Qiagen
Roche
Sanofi
Shire
UCB
US Pharma
AbbVie
Achillion
Acorda
Alexion
Alkermes
Allergan
Alnylam
AMAG
Amgen
Biogen
BioMarin
Bristol
Celgene
Endo
Gilead
ImmunoGen
Incyte
Ionis
Jazz
JnJ
Kite
Lilly
Medicines Co
Merck
Momenta
Mylan
Perrigo
Pfizer
Portola
Regeneron
Seattle
Teva
United
Valeant
Vertex
Japanese Pharma
Astellas
Chugai
Daiichi
Eisai
M Tanabe
Ono
Otsuka
Shionogi
Takeda
close
Peer Comparison
Total Revenue
Pharma Sales
COGS
SG&A
R&D
Trading Profit
Pretax Profit
Tax
Net Income
Gross Margin
SG&A Margin
R&D Margin
Trading Margin
Tax Rate
Changes since:
-12M
-3M
Last Global
-12M
-3M
Last Global
-12M
-3M
Last Global
-12M
-3M
Last Global
-12M
-3M
Last Global
-12M
-3M
Last Global
-12M
-3M
Last Global
-12M
-3M
Last Global
-12M
-3M
Last Global
R&D
R&D Pipeline
Sector P&L
EU Major
US Major
Japanese
US Big Biotech
close
Drugs
Biggest Drugs
Biggest Pipeline Drugs
Growers
Decliners
Upgrades
Downgrades
Variation
Drug List
Therapeutic Areas
Acid Disorders
Alzheimer's
Asthma / COPD
Breast Cancer
Colorectal Cancer
Depression
Diabetes
Dyslipidaemia
Haemophilia
HCV
HIV
Hypertension
Lung Cancer
Lymphoma (NHL/CLL)
Melanoma
Migraine
Multiple Sclerosis
Opthalmic (AMD / RVO / DME)
Osteoporosis
Prostate Cancer
Psoriasis
Rheumatoid Arthritis
Schizophrenia
Thrombosis
Mechanisms
Anti-PD(L)-1
Anti-PCSK-9
Anti-CD20
Anti-HER2
Anti-TNF
Anti-VEGF
Beta-amyloid
DPP-IV
GLP-1
Insulin Analogues
JAK Inhibitors
SGLT2
Xa Inhibitors
close
Valuation Summary
Summary Sheet
close
Valuation Metrics
DA-NET
P/E
P/S
PEG
Fundamentals
Growth - CAGRs
Drug Sales Expectation Change
close